Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medco Committed To Medicare Rx, But Not Part D; Backing The “Fallback”

Executive Summary

Medco is prepared to invest $150 mil. to create dedicated, Medicare-only facilities for the drug benefit in 2006, CFO JoAnn Reed told the Goldman Sachs conference in Laguna Niguel, Calif. June 9

You may also be interested in...



Medco Says It Is Ready For Part D: Will CMS Be?

Medco is "leaning" toward participating directly in the Medicare Part D stand-alone prescription drug insurance program in 2006, CEO David Snow said during an analyst meeting Nov. 11 in Philadelphia

Medco Says It Is Ready For Part D: Will CMS Be?

Medco is "leaning" toward participating directly in the Medicare Part D stand-alone prescription drug insurance program in 2006, CEO David Snow said during an analyst meeting Nov. 11 in Philadelphia

Medco Plans For Part D Will Be Formed After Election Day

Medco believes there may be ways to make the private drug insurance model attractive to pharmacy benefit management companies - but does not expect the issue to be resolved until after the elections

Related Content

UsernamePublicRestriction

Register

PS044158

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel